• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET Back to Search Results
Model Number 7510600
Device Problem Insufficient Information (3190)
Patient Problem Injury (2348)
Event Type  Injury  
Event Description
It was reported that the patient developed unspecified injuries following the use of rhbmp-2/acs in an unspecified spinal fusion surgery.No additional information was reported.
 
Manufacturer Narrative
(b)(4).Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.Products from multiple manufacturers were implanted during the procedure.Although it is unknown if any of the devices contributed to the reported event, we are filing this mdr for notification purposes.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported that (b)(6) 2010: patient underwent posterior fusion surgery using rhbmp2/acs, allograft paste and plif spacers.On (b)(6) 2013: patient underwent mri lumbar spine without contrast due to orthopedic hardware, pain, radiculopathy.Impression: native disc parenchyma noted at t12 --- l1.2 mm disc bulge; probable native disc without spacer material at l2 ---3.Central to right lateral disc protrusion measuring 2.5 mm; at the l3 --- 4 level there is a 3 mm impression upon the ventral subarachnoid space.This could represent disc bulge versus scar tissue; at the l4 - 5 level, there is a 4 mm impression upon the ventral subarachnoid space.This could represent disc bulging versus scar tissue.Fluid signal along the posterior periphery of this disc suggestive of annular tear; there is rounded fluid signal intensity structure along the posterior aspect of the thecal sac at the l4 - 5 level.This is felt to represent a seroma; at the l5 - s1 level, there is a 3 mm impression upon the ventral subarachnoid space.This likely represents a disc bulge.Can not rule out annular tear along the right lateral periphery of the interspace.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSE BONE GRAFT
Type of Device
FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK
1800 pyramid place
memphis TN 38132
Manufacturer Contact
huzefa mamoola
1800 pyramid place
memphis, TN 38132
9013963133
MDR Report Key4021560
MDR Text Key17630412
Report Number1030489-2014-03492
Device Sequence Number1
Product Code NEK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Attorney
Type of Report Initial,Followup
Report Date 06/23/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/19/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/01/2012
Device Model Number7510600
Device Catalogue Number7510600
Device Lot NumberM110812AAH
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received06/23/2015
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/01/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-